Page 3,738«..1020..3,7373,7383,7393,740..3,7503,760..»

Category Archives: Transhuman News

DARK TRANQUILITY (Interview excerpt) 2/20/14 @ DNA Lounge CAPITALCHAOSTV.COM – Video

Posted: March 25, 2014 at 7:44 am


DARK TRANQUILITY (Interview excerpt) 2/20/14 @ DNA Lounge CAPITALCHAOSTV.COM
http://www.facebook.com/CapitalChaos https://plus.google.com/u/0/b/118015811605522173893/118015811605522173893/photos http://www.capitalchaostv.com/ http://c...

By: Capital Chaos TV

See original here:
DARK TRANQUILITY (Interview excerpt) 2/20/14 @ DNA Lounge CAPITALCHAOSTV.COM - Video

Posted in DNA | Comments Off on DARK TRANQUILITY (Interview excerpt) 2/20/14 @ DNA Lounge CAPITALCHAOSTV.COM – Video

Glide gear DNA 1000 test – Video

Posted: at 7:44 am


Glide gear DNA 1000 test
Skate video to test performance of my Glide Gear DNA-1000. this video was shot on a nikon D5100 and a GoPro Hero 3 Black. Skater : Bas van Dreumel music : Th...

By: BerendJanV

Read more from the original source:
Glide gear DNA 1000 test - Video

Posted in DNA | Comments Off on Glide gear DNA 1000 test – Video

FRIDAY FIRE with JR Writer, DNA and Jinx Cruz – Video

Posted: at 7:44 am


FRIDAY FIRE with JR Writer, DNA and Jinx Cruz
Subscribe to our page: http://bit.ly/SVsBQC TWITTER: http://twitter.com/RealSway http://twitter.com/TheHappyHourwHB http://twitter.com/DJWonder http://twitte...

By: SwaysUniverse

Visit link:
FRIDAY FIRE with JR Writer, DNA and Jinx Cruz - Video

Posted in DNA | Comments Off on FRIDAY FIRE with JR Writer, DNA and Jinx Cruz – Video

DNA from fossils reveal origin of Norwegian lemmings

Posted: at 7:44 am

A new ancient DNA study shows that the Norwegian lemming has a unique history. In contrast to other mammals in Fennoscandia, the Norwegian lemming may have survived the last Ice Age in the far north, sealed off from the rest of the world by gigantic ice sheets. This conclusion is drawn by an international team of researchers in an article published this week in the journal Molecular Ecology.

The Norwegian lemming is an iconic small mammal that is unique to the Fennoscandian mountain tundra. Known for its dramatic fluctuations in population size, it is a keystone species in the mountain tundra ecosystem. But its origin has until now remained somewhat of a mystery.

Twenty thousand years ago, Fennoscandia was covered by a thick ice sheet. Animals and plants in the region are therefore thought to originate from populations that lived to the south or east of the ice sheet, and colonised Fennoscandia as the ice melted. With this in mind, and international team of scientists, led by researchers at the Swedish Museum of Natural History, set out to investigate from where the Norwegian lemming originated at the end of the last Ice Age. To do this, the researchers retrieved and analysed ancient DNA from lemming populations that surrounded the ice sheet during the last Ice Age.

- "We found that even though the populations surrounding the ice sheet were closely related to modern day lemmings, none of them were similar enough to be the direct ancestor of the Norwegian lemming," says Love Daln, Associate Professor at the Swedish Museum of Natural History.

After eliminating these populations as potential sources, the researchers concluded that the only remaining explanation was that the Norwegian lemming originates from a population that survived the last glaciation somewhere locally in Fennoscandia. The exact location where the Norwegian lemming could have survived the last glaciation is not clear, but likely places include coastal areas or mountain plateaus sticking out from the ice sheet.

"The Norwegian lemming is the only endemic mammal in Fennoscandia, and its unusual origin is probably the reason why," says Vendela Lagerholm, lead author on the study.

Story Source:

The above story is based on materials provided by Expertsvar. Note: Materials may be edited for content and length.

Read more:
DNA from fossils reveal origin of Norwegian lemmings

Posted in DNA | Comments Off on DNA from fossils reveal origin of Norwegian lemmings

DNA Mugshots

Posted: at 7:44 am

Hologic has named Eric Compton to the newly-established position of chief operating officer. He most recently served as worldwide president of Johnson & Johnson's Ortho Clinical Diagnostics business. Hologic also named Claus Egstrand its new senior VP and general manager, international. He previously held senior positions at Merck, Stryker, Pfizer Consumer Healthcare, and Pharmacia. In addition, David Harding, who previously served as Hologic's group senior VP and GM of women's health, has been named senior VP of corporate strategy. CFO Glenn Muir, who began serving in that post in 1992, will retire from the firm at the end of November.

SISCAPA Assay Technologies has named Selena Larkin its vice president of marketing and sales. Larkin joins the mass spec assay firm after recently serving as global director of pharmaceutical strategy at Agilent Technologies. She previously held positions at Applied Biosystems/Sciex and Irvine Scientific.

Sequenom announced this week that CEO Harry Hixson plans to retire from that position in June, at the time of the company's stockholder meeting. Current President and Chief Operating Officer William Welch will assume Hixson's position upon his retirement. Hixson will continue to serve as chairman of the firm's board of directors, a title he has held since 2003. Welch also will be nominated to serve on the board at the annual meeting, Sequenom said. Also, CFO Paul Maier also will retire from his job in June, but will continue to work with the company as a consultant. Current VP and Chief Accounting Officer Carolyn Beaver will replace Maier as CFO upon his retirement. She previously was corporate VP and controller of Beckman Coulter. In addition, Dirk van den Boom will be promoted to be chief scientific and strategy officer. He has been with Sequenom since 1998, and he recently was the company's executive VP of R&D and chief technology officer.

Former Life Technologies executive Paul Grossman has joined Telegraph Hill Partners as a venture partner. Grossman previously was head of global strategy and corporate development at Life Tech, and he also held the same position at Invitrogen. Before he joined Invitrogen, Grossman held a variety of leadership roles at Applied Biosystems, including as a research scientist and patent attorney, VP of intellectual property, and VP of strategy and business development.

See the original post here:
DNA Mugshots

Posted in DNA | Comments Off on DNA Mugshots

Evolution Lesson 10 – DNA & Human Genome (2) – Video

Posted: at 7:43 am


Evolution Lesson 10 - DNA Human Genome (2)
One year study of Evolution DNA by Dr. Bo Kirkwood bokirkwood@ aol.com.

By: norrislong

Visit link:
Evolution Lesson 10 - DNA & Human Genome (2) - Video

Posted in Genome | Comments Off on Evolution Lesson 10 – DNA & Human Genome (2) – Video

Could far-flung mutations in the genome activate cancer-causing genes? – Video

Posted: at 7:43 am


Could far-flung mutations in the genome activate cancer-causing genes?
A Perspective published with his postdocs, Hans-Martin Herz, Ph.D. and Deqing Hu, Ph.D., in the March 20th issue of Molecular Cell. In it, they summarize how...

By: Stowers Institute

More:
Could far-flung mutations in the genome activate cancer-causing genes? - Video

Posted in Genome | Comments Off on Could far-flung mutations in the genome activate cancer-causing genes? – Video

Genome: A healthcare revolution – Newsnight – Video

Posted: at 7:43 am


Genome: A healthcare revolution - Newsnight
Rohan Silva investigates the potential of the human genome in creating a personalised healthcare revolution Follow @BBCNewsnight on Twitter https://twitter.c...

By: BBC Newsnight

Here is the original post:
Genome: A healthcare revolution - Newsnight - Video

Posted in Genome | Comments Off on Genome: A healthcare revolution – Newsnight – Video

IBM's Watson helps genome research

Posted: at 7:43 am

IBM says it is joining a 'genomic medicine' initiative, using its Watson supercomputer to deliver customised treatment options for cancer patients.

The US computing group said on Wednesday it was teaming with the New York Genome Center in a program to help doctors develop treatments tailored to each patient's genetic makeup.

The first phase will help oncologists find treatments for patients with glioblastoma, an aggressive and malignant brain cancer that kills more than 13,000 people in the United States each year.

The supercomputer will be used to scan medical journals, new studies and clinical records and correlate those with a patient's genetic mutations.

'Clinicians lack the tools and time required to bring DNA-based treatment options to their patients,' said a statement from IBM and the Genome Center.

'This joint NYGC Watson initiative aims to speed up this complex process, identifying patterns in genome sequencing and medical data to unlock insights that will help clinicians bring the promise of genomic medicine to their patients.'

Because Watson can continually 'learn' from new data, the initiative aims to update databases that give doctors the best treatment options.

'Since the human genome was first mapped more than a decade ago, we've made tremendous progress in understanding the genetic drivers of disease,' said Robert Darnell, president and scientific director of the centre.

'The real challenge before us is how to make sense of massive quantities of genetic data and translate that information into better treatments for patients.

'Applying the cognitive computing power of Watson is going to revolutionise genomics and accelerate the opportunity to improve outcomes for patients with deadly diseases.'

Read the original here:
IBM's Watson helps genome research

Posted in Genome | Comments Off on IBM's Watson helps genome research

INOKI GENOME FIGHT 1 – Video

Posted: at 7:43 am


INOKI GENOME FIGHT 1
.

By: inokigenome

See the rest here:
INOKI GENOME FIGHT 1 - Video

Posted in Genome | Comments Off on INOKI GENOME FIGHT 1 – Video

Page 3,738«..1020..3,7373,7383,7393,740..3,7503,760..»